In its prospectus, page 31, HLF's EBITDA (LTM Dec 21) is given as 0.3m (not qualified as underlying or normalised or statutory or otherwise). So, to go from 0.3 to 5.0 in 3 months, I felt that is a stretch.
I just spend some time to find out what exactly the expenses of the "other segments" of $2,551,651 are; but could not find numbers or explanations that tally up (for me at least).
"Total share-based payments expense recorded in the profit or loss for the period ended 30 September 2021 amounted
to $1,323,397 (2020: $1,251,216)".
It is interesting to note that this figure was that high in the year before. In any case, it only accounts for roughly half of it. In my view, these are the things that are a problem with normalisation that I think we see far too often. I think the normalisation expenses should not re-occur, if they do, then they should not be normalised - as they seem part of the standard business.
Time will tell, only 14 days to go.
- Forums
- ASX - By Stock
- HLF
- Who is participating in the SPP?
Who is participating in the SPP?, page-234
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add HLF (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online